Atlantic Pharmaceuticals Inc. Company Profile
Atlantic Pharmaceuticals, Inc., is a privately held specialty pharmaceutical company dedicated to the discovery and development of innovative, late-stage therapies for substance abuse and pain-related conditions and diseases. Our products target therapeutic opportunities utilizing molecules shown to be safe and effective with formulations that are protected by intellectual property. We believe that our approach will lead to improved patient care, reduced healthcare costs and a rapid time to market.
News from Atlantic Pharmaceuticals Inc.:
Atlantic Pharmaceuticals, Inc. Announces Third Patent Issuance on SMART/Script™ Abuse Deterrent Drug Delivery System
ATLANTA, Aug. 21, 2013 /PRNewswire/ — Atlantic Pharmaceuticals, Inc., today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8,507,001 that contains claims which cover Atlantic's SMART/Script™ abuse deterrent drug delivery system. SMART/Script™ is designed to prevent dose dumping of orally delivered prescription opioids and may sequester and reduce drug […]
Atlantic Pharmaceuticals Announces Successful Pre-IND Meeting with the FDA on Immediate Release, Abuse-Deterrent Hydrocodone
ATLP-03 uses SMART/Script™ drug delivery technology to deter prescription drug abuse ATLANTA, Aug. 13, 2013 /PRNewswire/ — Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical company that has developed and is commercializing a unique technology to deter prescription drug abuse today announced that it has completed a successful Pre-Investigational New Drug Meeting with the Food and Drug Administration on […]
Atlantic Pharmaceuticals President Named Health Care Hero Finalist in Atlanta Business Chronicle for Drug Abuse Deterrent Technology
ATLANTA, May 20, 2013 /PRNewswire/ — Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical company that has developed and is commercializing a unique technology to deter prescription drug abuse today announced that its founder and President, Anthony Soscia, has been chosen as a finalist for the Atlanta Business Chronicle's Health-Care Heroes Awards. The awards are presented annually by […]
Atlantic Pharmaceuticals, Inc. Announces Two Patent Issuances for Its Tamper-Resistant Pharmaceutical Platform
ATLANTA, Dec. 20, 2012 /PRNewswire/ — Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical company, today announced that new patents have been issued by the U.S. Patent and Trademark Office (USPTO) relating to its tamper-resistant SMART/Script™ drug delivery platform. U.S. Patent Nos. 8,187,636 and 8,349,362 contain claims that cover Atlantic's proprietary tamper-resistant platform which are designed to resist […]
Atlantic Pharmaceuticals, Inc. Announces Completion of Successful Pre-IND Meeting with FDA for Abuse Deterrent Narcotic
ATLANTA, June 23, 2009 — Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical company, today announced that it has completed a pre-investigational new drug (PIND) meeting with the Food and Drug Administration (FDA) for guidance on a mutually acceptable regulatory pathway for submission of an abuse deterrent immediate release oxycodone. Atlantic's proprietary oral delivery technology Smart/Script(TM) is […]
